Interactions between catecholamines and serotonin: relevance to the pharmacology of schizophrenia.
Svensson
T H
TH
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Mathé
J M
JM
Nomikos
G G
GG
Schilström
B
B
Marcus
M
M
Fagerquist
M
M
D018750:6-Cyano-7-nitroquinoxaline-2,3-dione / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000502:physiology*; D002395:Catecholamines / Q000502:physiology*; D016291:Dizocilpine Maleate / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D006801:Humans; D007608:Kainic Acid / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D009714:Nucleus Accumbens / Q000187:drug effects / Q000502:physiology; D016318:Quisqualic Acid / Q000494:pharmacology; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology; D012559:Schizophrenia / Q000503:physiopathology*; D012701:Serotonin / Q000502:physiology*; D013239:Stereotyped Behavior / Q000187:drug effects; D013681:Tegmentum Mesencephali / Q000187:drug effects / Q000502:physiology
D002395:Catecholamines; D016194:Receptors, N-Methyl-D-Aspartate; D012701:Serotonin; D016291:Dizocilpine Maleate; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; D016318:Quisqualic Acid; D007608:Kainic Acid; D004298:Dopamine